Renol Polychem Limited IPO 2025: Complete Investment Guide

About Renol Polychem Ltd.

Ultra brings you a detailed overview of the Renol Polychem Limited IPO, launching on the NSE SME platform. This comprehensive guide covers IPO details, share price, GMP, subscription status, business fundamentals, and whether the issue is worth considering.

Founded in 2008, Renol Polychem Limited specializes in manufacturing color masterbatches, additive masterbatches, pigments, and polymer compounds. Serving sectors like packaging, automotive, consumer goods, and agriculture, the company operates with a modest yet highly diversified product range.

As of September 2024, the company employed 15 employees and has shown explosive growth—revenue surged by 859%, and PAT rose by 226% year-on-year.

Renol Polychem IPO Price & Lot Size

• Fixed Price Issue at ₹105 per share

• Minimum Application (Retail): ₹2,52,000 (2,400 shares)

• HNI Minimum Application: ₹3,78,000 for 3 lots (3,600 shares)

Renol Polychem IPO Subscription Status: How Did It Fare?

As of final subscription data:

• Retail: ~1.5×

• HNI: ~1.2×

• QIB & Anchor: Moderately subscribed

Total subscription reflects moderate investor interest—reasonable demand given SME IPO category norms.

Renol Polychem IPO GMP Today

Grey market tracking suggests a GMP of ₹10–₹15 per share, implying a potential listing price of ₹115–₹120. While GMP trends are speculative, they indicate positive post-listing sentiment.

Strategic Strengths of Renol Polychem

• Wide product portfolio: color, filler, and additive masterbatches

• Broad industry application: packaging, auto parts, consumer goods, PVC pipes

• Client relationships: with consistent manufacturing and vendor support

• Sharp financial growth: revenue and profits up sharply in FY 2025

• Compact operations: lean workforce and scalable infrastructure

Renol Polychem IPO Review: Key Takeaways

Pros:

• Exceptional revenue and profit growth

• Strong product diversification

• Promising sectors such as packaging and automotive

• Fixed IPO pricing reduces uncertainty

Cons:

• Very high minimum ticket size for retail investors (₹2.5 lakh)

• Relatively small scale vs. established peers

• SME IPO liquidity may be limited post-listing

Bottomline: High-risk, high-growth SME play—not ideal for conservative investors. Suitable for those expecting aggressive short-term returns or speculative listing gains based on GMP trends.

FAQs: Renol Polychem Limited IPO

1. What is the Renol Polychem IPO date?

IPO opened on July 31, 2025, and closed on August 4, 2025.

2. What is the IPO share price?

The fixed price was set at ₹105 per share.

3. What is the lot size and minimum investment?

Minimum is 2,400 shares; investment required = ₹2,52,000.

4. What is the current GMP?

GMP stands at approximately ₹10–₹15 per share, indicative of potential listing gains.

5. When is the listing date?

Shares are tentatively expected to list on August 7, 2025, on NSE SME.

Final Thoughts

Renol Polychem IPO offers an aggressive growth story in a niche plastic additives sector. While its high subscription threshold and limited scale pose risks, the IPO may yield healthy listing returns for speculative investors. Always consider your investment strategy, risk appetite, and consult a financial advisor before subscribing.

For curated investment ideas beyond IPOs—explore alternatives on Ultra, your partner for smart investment access.